Abstract: A method for producing a spectacle lens, the method including: determining the positions of at least three marks so as to specify the center position of a frame shape on the basis of the at least three marks; making marks at the determined positions; calculating the shape of a non-optical surface of a semifinished lens with respect to the center position when processing the non-optical surface according to a prescription; and processing the non-optical surface into the calculated shape with respect to the center position. When the semifinished lens is viewed in an optical axis direction, the at least three marks include a pair of marks located on a first straight line passing through the center position and a mark located on a second straight line that is orthogonal to the first straight line and passes through the center position.

Abstract: An agent device includes: a plurality of agent function units, in which each of the agent function units provides a service including a voice response to an occupant of a vehicle in response to an utterance of the occupant; and a manager which, when any of the plurality of agent function units is being activated and the predetermined same operation is performed on the plurality of agent function units by the occupant of the vehicle, causes the agent function unit which is being activated to stop.

Abstract: The present invention relates to a pyrimidine compound or a pharmaceutically acceptable salt thereof represented by the following formula [I] wherein each symbol is as defined in the specification and a method of therapeutically or prophylactically treating an undesirable cell proliferation, comprising administering such a compound. The compound of the present invention has superior activity in suppressing undesirable cell proliferation, particularly, an antitumor activity, and is useful as an antitumor agent for the prophylaxis or treatment of cancer, rheumatism, and the like. In addition, the compound of the present invention can be a more effective antitumor agent when used in combination with other antitumor agents such as an alkylating agent or metabolism antagonist.

Abstract: A speech processing system includes one or more analog microphones each arrangeable within a cabin and configured to output a first analog speech signal, one or more digital microphones each arrangeable within the cabin and configured to output a digital speech signal, a digital-to-analog convertor configured to convert the digital speech signal into a second analog speech signal, and a speech signal processer including a delay processer configured to delay at least the first analog speech signal on the basis of a delay time period when the digital-to-analog convertor converts the digital speech signal, which is collected at the same time point as the first analog speech signal, into the second analog speech signal and output the delayed first analog speech signal as a third analog speech signal and configured to perform speech signal processing on the basis of the second analog speech signal and the third analog speech signal.

Abstract: An agent device includes one or more agent controllers configured to provide a service including causing an output device to output a response of voice according to a voice of an occupant which is collected in a vehicle interior of a vehicle, a receiver configured to receive an input from the occupant, and a starting method setter configured to change or add a starting method of the agent controller on the basis of content received by the receiver.

Abstract: A semiconductor memory device includes a substrate, a controller, a semiconductor memory component, first and second capacitors, and a jumper element. The substrate has a conductor pattern. The conductor pattern includes a first conductor portion and a second conductor portion. The first conductor portion overlaps at least a part of the first capacitor in a thickness direction of the substrate and is electrically connected to the first capacitor. The second conductor portion overlaps at least a part of the second capacitor in the thickness direction of the substrate and is electrically connected to the second capacitor. The first conductor portion and the second conductor portion are separated from each other, and are electrically connected to each other by the jumper element.

Abstract: Provided is an agent for the treatment or prophylaxis of inflammatory diseases, allergic diseases, autoimmune diseases, transplant rejection or the like. A compound represented by the following formula [I] or a pharmaceutically acceptable salt thereof, or a solvate thereof: wherein each symbol is as described in the specification.

Abstract: The present invention aims to provide a new method for producing an indole compound or a salt thereof, which has an ITK inhibitory action, and is useful for the prophylaxis or treatment of inflammatory disease.

Abstract: Provided is an information processing apparatus including an acquiring unit that acquires cell information indicating a state of a cell from production of a pluripotent stem cell to differentiation of the pluripotent stem cell into a specific differentiated cell by differentiation induction, and process history information indicating a history of a processing process for obtaining the differentiated cell, and a deriving unit that derives differentiation potency information indicating differentiation potency of the pluripotent stem cell based on the cell information and the process history information which are acquired by the acquiring unit.

Abstract: An agent device includes one or more agent controllers configured to provide a service including causing an output device to output a response of voice according to a voice of an occupant which is collected in a vehicle interior of a vehicle, a receiver configured to receive an input from the occupant, and a starting method setter configured to change or add a starting method of the agent controller on the basis of content received by the receiver.

Abstract: An agent device includes: a plurality of agent function units, each of the plurality of agent function units being configured to provide services including outputting a response to an output unit in response to an utterance of an occupant of a vehicle; a recognizer configured to recognize a request included in the occupant's utterance; and an agent selector configured to output a request recognized by the recognizer to the plurality of agent function units and select an agent function unit which outputs a response to the occupant's utterance to the output unit among the plurality of agent function units on the basis of the result of a response of each of the plurality of agent function units.

Abstract: An agent device includes: a plurality of agent function units, in which each of the agent function units provides a service including a voice response to an occupant of a vehicle in response to an utterance of the occupant; and a manager which, when any of the plurality of agent function units is being activated and the predetermined same operation is performed on the plurality of agent function units by the occupant of the vehicle, causes the agent function unit which is being activated to stop.

Abstract: Provided is an agent for the treatment or prophylaxis of inflammatory diseases, allergic diseases, autoimmune diseases, transplant rejection or the like. A compound represented by the following formula [I] or a pharmaceutically acceptable salt thereof, or a solvate thereof: wherein each symbol is as described in the specification.

Abstract: A semiconductor memory device includes a substrate, a controller, a semiconductor memory component, first and second capacitors, and a jumper element. The substrate has a conductor pattern. The conductor pattern includes a first conductor portion and a second conductor portion. The first conductor portion overlaps at least a part of the first capacitor in a thickness direction of the substrate and is electrically connected to the first capacitor. The second conductor portion overlaps at least a part of the second capacitor in the thickness direction of the substrate and is electrically connected to the second capacitor. The first conductor portion and the second conductor portion are separated from each other, and are electrically connected to each other by the jumper element.

Abstract: A semiconductor memory device includes a substrate, a controller, a semiconductor memory component, first and second capacitors, and a jumper element. The substrate has a conductor pattern. The conductor pattern includes a first conductor portion and a second conductor portion. The first conductor portion overlaps at least a part of the first capacitor in a thickness direction of the substrate and is electrically connected to the first capacitor. The second conductor portion overlaps at least a part of the second capacitor in the thickness direction of the substrate and is electrically connected to the second capacitor. The first conductor portion and the second conductor portion are separated from each other, and are electrically connected to each other by the jumper element.

Abstract: The present invention relates to a pyrimidine compound or a pharmaceutically acceptable salt thereof represented by the following formula [I] wherein each symbol is as defined in the specification and a method of therapeutically or prophylactically treating an undesirable cell proliferation, comprising administering such a compound. The compound of the present invention has superior activity in suppressing undesirable cell proliferation, particularly, an antitumor activity, and is useful as an antitumor agent for the prophylaxis or treatment of cancer, rheumatism, and the like. In addition, the compound of the present invention can be a more effective antitumor agent when used in combination with other antitumor agents such as an alkylating agent or metabolism antagonist.

Abstract: A semiconductor memory device includes a substrate, a controller, a semiconductor memory component, first and second capacitors, and a jumper element. The substrate has a conductor pattern. The conductor pattern includes a first conductor portion and a second conductor portion. The first conductor portion overlaps at least a part of the first capacitor in a thickness direction of the substrate and is electrically connected to the first capacitor. The second conductor portion overlaps at least a part of the second capacitor in the thickness direction of the substrate and is electrically connected to the second capacitor. The first conductor portion and the second conductor portion are separated from each other, and are electrically connected to each other by the jumper element.

Abstract: The present invention aims to provide a new method for producing an indole compound or a salt thereof, which has an ITK inhibitory action, and is useful for the prophylaxis or treatment of inflammatory disease.

Abstract: Provided is an agent for the treatment or prophylaxis of inflammatory diseases, allergic diseases, autoimmune diseases, transplant rejection or the like. A compound represented by the following formula [I] or a pharmaceutically acceptable salt thereof, or a solvate thereof: wherein each symbol is as described in the specification.

Abstract: The present invention relates to a pyrimidine compound or a pharmaceutically acceptable salt thereof represented by the following formula [I] wherein each symbol is as defined in the specification and a method of therapeutically or prophylactically treating an undesirable cell proliferation, comprising administering such a compound. The compound of the present invention has superior activity in suppressing undesirable cell proliferation, particularly, an antitumor activity, and is useful as an antitumor agent for the prophylaxis or treatment of cancer, rheumatism, and the like. In addition, the compound of the present invention can be a more effective antitumor agent when used in combination with other antitumor agents such as an alkylating agent or metabolism antagonist.